Puthenveedu, Manojkumar A
- University of Michigan · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #7,095
- R01 Holder
- Long-Funded
- Mentor
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$1.3M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#7,095
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Puthenveedu, Manojkumar A as a PI. Multi-PI records show the full award amount for context.
- 5T32GM145470-02T32Contact PICellular and Molecular Biology at MichiganUniversity of Michigan · Pharmacology (NIH department code)$848.9Kaward amount
- 5R01DA055026-02R01Contact PIRegulated trafficking and compartmentalized signaling of opioid receptorsUniversity of Michigan · Pharmacology (NIH department code)$461.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Puthenveedu, Manojkumar A as a PI.
FY2023 award administered by University of Michigan (MI).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardUniversity of Michigan
- 2010$500K Cumulative Funding
- 2013$1M Cumulative Funding
- 2013R01 Grant Holder
- 2018$2M Cumulative Funding
- 2020Entered Top 50% NationallyRanked #2786
- 2020Entered Top 25% NationallyRanked #2786
- 2022$5M Cumulative Funding